RetractedReviewFrontiers in immunology2022

Dysregulation of Survivin-Targeting microRNAs in Autoimmune Diseases: New Perspectives for Novel Therapies.

Navid Shomali et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.